861 related articles for article (PubMed ID: 21238536)
21. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
22. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.
Gómez R; Simón C; Remohí J; Pellicer A
Biol Reprod; 2003 Jun; 68(6):2164-71. PubMed ID: 12606463
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS).
Scotti L; Abramovich D; Pascuali N; de Zúñiga I; Oubiña A; Kopcow L; Lange S; Owen G; Tesone M; Parborell F
Mol Cell Endocrinol; 2013 Jan; 365(2):223-30. PubMed ID: 23123737
[TBL] [Abstract][Full Text] [Related]
24. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
[TBL] [Abstract][Full Text] [Related]
25. Expression of angiopoietin (ANPT)-1, ANPT-2 and their receptors in dominant follicles during periovulatory period in GnRH-treated cow.
Shimizu T; Berisha B; Schams D; Miyamoto A
Reprod Domest Anim; 2007 Apr; 42(2):221-4. PubMed ID: 17348983
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
Sridaran R; Ghose M; Mahesh VB
Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
[TBL] [Abstract][Full Text] [Related]
27. Changes of mRNA expression of vascular endothelial growth factor, angiopoietins and their receptors during the periovulatory period in eCG/hCG-treated immature female rats.
Miyabayashi K; Shimizu T; Kawauchi C; Sasada H; Sato E
J Exp Zool A Comp Exp Biol; 2005 Jul; 303(7):590-7. PubMed ID: 15945074
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of transforming growth factor-alpha, epidermal growth factor, and vascular endothelial growth factor expression in hyperstimulated rat ovary.
Ozcakir HT; Giray SG; Ozbilgin MK; Uyar Y; Lacin S; Caglar H
Acta Obstet Gynecol Scand; 2005 Sep; 84(9):887-93. PubMed ID: 16097982
[TBL] [Abstract][Full Text] [Related]
29. Establishment of heterogeneity among blood vessels: hormone-influenced appearance of hepatic lipase in specific subsets of the ovarian microvasculature.
Hixenbaugh EA; Strauss JF; Paavola LG
Anat Rec; 1993 Apr; 235(4):487-500. PubMed ID: 8465984
[TBL] [Abstract][Full Text] [Related]
30. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
[TBL] [Abstract][Full Text] [Related]
31. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
[TBL] [Abstract][Full Text] [Related]
32. Steroidogenic impairment due to reduced ovarian transcription of cytochrome P450 side-chain-cleavage (P450scc) and steroidogenic acute regulatory protein (StAR) during experimental nephrotic syndrome.
Peña-Rico M; Guadalupe Ortiz-López M; Camacho-Castillo L; Cárdenas M; Pedraza-Chaverri J; Menjívar M
Life Sci; 2006 Jul; 79(7):702-8. PubMed ID: 16574160
[TBL] [Abstract][Full Text] [Related]
33. Changes in vascular leakage and expression of angiopoietins in the corpus luteum during pregnancy in rats.
Matsuoka-Sakata A; Tamura H; Asada H; Miwa I; Taketani T; Yamagata Y; Sugino N
Reproduction; 2006 Feb; 131(2):351-60. PubMed ID: 16452728
[TBL] [Abstract][Full Text] [Related]
34. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist.
Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R
Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337
[TBL] [Abstract][Full Text] [Related]
35. [Regulation of follicular luteinization by an agonist of gonadotropin-releasing hormone (GnRH)].
Andreu C; Parborell F; Vanzulli S; Tesone M
Medicina (B Aires); 1997; 57(1):83-6. PubMed ID: 9435376
[TBL] [Abstract][Full Text] [Related]
36. Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging.
Yeh J; Kim BS; Peresie J
Fertil Steril; 2008 May; 89(5 Suppl):1546-56. PubMed ID: 17889862
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
Gómez R; Simón C; Remohí J; Pellicer A
Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
[TBL] [Abstract][Full Text] [Related]
38. Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/AKT signaling pathway.
Abramovich D; Irusta G; Parborell F; Tesone M
Fertil Steril; 2010 Mar; 93(5):1369-77. PubMed ID: 19328472
[TBL] [Abstract][Full Text] [Related]
39. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy.
Sridaran R; Philip GH; Li H; Culty M; Liu Z; Stocco DM; Papadopoulos V
J Mol Endocrinol; 1999 Feb; 22(1):45-54. PubMed ID: 9924179
[TBL] [Abstract][Full Text] [Related]
40. Phosphodiesterase inhibitor 3-isobutyl-methyl-xanthine affects rabbit ovaries and oviduct.
Sirotkin AV; Chrenek P; Chadio S; Xylouri E; Fotopouloy H; Makarevich AV
Eur J Pharmacol; 2010 Sep; 643(1):145-51. PubMed ID: 20599929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
